heart failure
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.
Quest Diagnostics, Zora Biosciences Sign Licensing Agreement for Cardiovascular Biomarkers
The company signed a non-exclusive license for Zora's ceramide markers and plans to launch a test based on the markers as early as next year.
Wyss Institute Developing Multiplex Electrochemical Testing Platform for Multiple Disease Conditions
The iQ Group Global is integrating the Wyss Institute's technology with its own organic thin-film biosensor platform for SARS-CoV-2 serology testing.Â
The firm anticipates that point-of-care adoption may attract licensing deals from companies interested in adding the biomarkers to their large laboratory analyzers.
Ortho Clinical Diagnostics Receives Health Canada Approval for High Sensitivity Troponin I Assay
Ortho's assay, which aids in quickly and accurately diagnosing heart attacks, runs on its new Vitros XT 7600 Integrated System, among other Ortho systems.